SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

  • There is currently no data for IGV

Interim Management Statement - 3rd Quarter

13 Aug 2019 15:19

RNS Number : 9065I
Income & Growth VCT (The) PLC
13 August 2019
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2019

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2019. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2019

At 31 March 2019

 

Net assets attributable to shareholders

£84,211,371

£81,438,038

Shares in issue

103,827,380

104,363,865

Net asset value (NAV) per share

81.11p*

78.03p

Cumulative dividends paid to date per share

111.50p*

111.50p

Total return per share since inception (NAV basis)

192.61p

189.53p

*Figures are quoted prior to the 1.50 pence dividend referred to below.

 

INTERIM DIVIDEND

 

The Board declared an interim dividend of 1.50 pence per share for the year ending 30 September 2019, comprising 1.00 penny and 0.50 pence from capital. This dividend was paid to shareholders on 12 July 2019 to shareholders on the Register on 14 June 2019 and brings cumulative dividends paid per share to 113.00 pence per share, and also reduces the Company's Net Asset Value by a corresponding amount.

 

SHARE BUYBACKS

 

On 5 June 2019, the Company purchased 300,000 of the Company's own ordinary shares at a price of 67.50 pence per share for cancellation.

 

On 7 June 2019, the Company purchased 236,485 of the Company's own ordinary shares at a price of 70.25 pence for cancellation.

 

After the period end, with effect from 1 August 2019, the Board changed its share buyback policy objective of maintaining the discount to Net Asset Value at which the Company's shares may trade in the market from approximately 10% or less, to approximately 5% or less. In pursuing this policy, the Board's priority will remain to ensure that it is acting prudently and in the interests of the remaining shareholders of the Company. Share buybacks will continue to be entirely at the Board's discretion and will be subject to the Company having sufficient funds available for such a purpose. They will also continue to be subject to prevailing market conditions, the Listing Rules and any applicable law and regulatory restrictions at the relevant time. Shares bought back in the market will ordinarily be cancelled.

 

INVESTMENT ACTIVITY

 

Investments during the period

On 13 May 2019, the Company invested £1.53 million into a new investee company, Arkk Consulting, which provides services and software to enable organisations to remain compliant with regulatory reporting requirements.

 

On 22 May 2019, the Company invested £0.93 million into a new investee company, Parsley Box, which is a UK direct to consumer supplier of home delivered ambient ready meals for the elderly.

 

Realisations during the period

On 10 May 2019, the Company sold its remaining investment in Plastic Surgeon to Polygon Group for £1.22 million. Over the eleven years this investment was held, it generated proceeds of £2.27 million compared to an original investment cost £0.41 million, which is a multiple on cost of 5.6 x and an IRR of 20.5%.

 

On 28 June 2019, the Company sold its investment in ASL Technology for £4.79 million. Over the eight and a half years this investment was held, it generated proceeds of £5.94 million compared to an original investment cost of £2.72 million, which is a multiple on cost of 2.2x and an IRR of 12.6%.

 

Transactions after the period end

After the period end, the Company made a follow-on investment of £0.62 million into MPB Group, a leading online marketplace for camera and video equipment.

 

On 2 August 2019, £0.17 million of contingent consideration was received as part of the sale of Entanet Holdings in August 2017.

On 6 June 2019, the Company realised part of its investment in Master Removers Group generating proceeds receivable of £0.51 million, as part of a transaction which also increased the Company's equity interest from 6.3% to 9.6%.

 

PLANNED FUNDRAISING

As announced recently, the Board intends to launch offers for subscription for new ordinary shares in the autumn, full details of which will be contained in the prospectus that will be sent to all registered shareholders.

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Rob Brittain, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUORSRKKAWAAR
Date   Source Headline
7th Nov 20221:00 pmRNSDirector/PDMR Shareholding
7th Nov 202212:34 pmRNSIssue of Equity and Total Voting Rights
7th Nov 20227:00 amRNSDirectorate Change
3rd Nov 20227:00 amRNSNet Asset Value(s)
17th Oct 20221:35 pmRNSOffer for Subscription – Update
17th Oct 20221:35 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:00 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20229:03 amRNSTransaction in Own Shares
14th Sep 20225:25 pmRNSInterim Management Statement
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
26th Aug 20223:34 pmRNSDirector/PDMR Shareholding
26th Aug 20222:45 pmRNSIssue of Equity and Total Voting Rights
23rd Aug 20227:00 amRNSTransaction in Own Shares
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
8th Jul 202210:01 amRNSDirector/PDMR Shareholding
8th Jul 202210:00 amRNSIssue of Equity and Total Voting Rights
13th Jun 20222:00 pmRNSRealisation of investment - Media Business Insight
13th Jun 202210:00 amRNSRealisation of investment - Media Business Insight
10th Jun 20224:45 pmRNSTransaction in Own Shares
25th May 202210:00 amRNSHalf-year Report
9th Mar 20224:30 pmRNSDirector/PDMR Shareholding
9th Mar 20222:30 pmRNSIssue of Equity & Total Voting Rights
4th Mar 20221:15 pmRNSNet Asset Value(s)
25th Feb 20223:00 pmRNSInterim Management Statement
23rd Feb 20226:29 pmRNSResult of AGM
25th Jan 20223:15 pmRNSDirector Declaration
21st Jan 202212:05 pmRNSFundraising Update
20th Jan 20221:15 pmRNSPublication of a Prospectus and Circular
7th Jan 202210:05 amRNSDirector/PDMR Shareholding
7th Jan 202210:00 amRNSIssue of Equity and Total Voting Rights
4th Jan 20227:00 amRNSTransaction in Own Shares
20th Dec 20216:02 pmRNSReplacement - Annual Financial Report
20th Dec 20215:30 pmRNSAnnual Financial Report
6th Dec 20215:00 pmRNSDividend Declaration - Correction
6th Dec 20217:00 amRNSDirectorate Change
3rd Dec 20219:00 amRNSRealisation of investment - Vian Marketing Limited
2nd Dec 202110:20 amRNSDividend Declaration
8th Nov 20217:00 amRNSIntention to Launch Joint Offers for Subscription
7th Oct 20213:00 pmRNSRealisation of Proactive Group Holdings Inc
1st Oct 20217:11 amRNSCompletion of change in management arrangements
1st Oct 20217:00 amRNSCompletion of Acquisition
28th Sep 20217:39 amRNSTransaction in Own Shares
16th Sep 20217:00 amRNSInterim Management Statement - 3rd Quarter
10th Sep 20217:06 amRNSProposed change in management arrangements
10th Sep 20217:00 amRNSAcquisition and proposed placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.